Warning Letters and Notice of Violation Letters to Pharmaceutical Companies
Untitled Letters 2021
These letters are supplied by the CDER Freedom of Information Office and only covers Office of Prescription Drug Promotion's untitled letters. The agency may have redacted or edited some of the letters to remove confidential information.
About Warning and Close-Out Letters
This page reviews the types of warning letters found on the FDA website.
Archived CDER Warning Letters (1998-2016)
Freedom of Information (FOI)
Visit the FOI page for instructions on how to submit an FOI request or for more information on the status of an issue in a particular warning letter or notice of violation.